Designed to objectively cover the process of bench to bedside development of cardiovascular drug, device and cell therapy, and to bring you the information you need most in a timely and useful format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic field.

Homing in on the most exciting work being done on new therapeutic agents, Cardiovascular Drugs and Therapy focusses on developments in atherosclerosis, hyperlipidemia, diabetes, ischemic syndromes and arrhythmias. The Journal is an authoritative source of current and relevant information that is indispensable for basic and clinical investigators aiming for novel, breakthrough research as well as for cardiologists seeking to best serve their patients.

Providing you with a single, concise reference tool acknowledged to be among the finest in the world, Cardiovascular Drugs and Therapy is listed in Web of Science and PubMed/Medline among other abstracting and indexing services. The regular articles and frequent special topical issues equip you with an up-to-date source defined by the need for accurate information on an ever-evolving field. Cardiovascular Drugs and Therapy is a careful and accurate guide through the maze of new products and therapies which furnishes you with the details on cardiovascular pharmacology that you will refer to time and time again.

Five Reasons to Publish Your Article in Cardiovascular Drugs and Therapy:

· High usage: Articles frequently downloaded from month to month

· Wide distribution: Institutions worldwide having full text access

· Efficient handling: 18 days between submission and first decision

· Fast publication: 17 days between acceptance and online publication

· International readership: North America, Asia, Europe, Middle East and South America

100% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again
Editor-in-chief
  • Willem J. Remme
Impact
Impact factor: 4.181 (2018)
Five year impact factor: 3.367 (2018)
Speed
Submission to first decision: 31 days
Acceptance to publication: 20 days
Usage
Downloads: 99,332 (2018)
Publishing model
Hybrid. Open Choice – What is this?

Articles

  1. Content type: ORIGINAL ARTICLE

      |  

    Authors: Rita Pavasini, Elisa Maietti, Elisabetta Tonet, Giulia Bugani, Matteo Tebaldi, Simone Biscaglia, Paolo Cimaglia, Matteo Serenelli, Rossella Ruggiero, Francesco Vitali, Marcello Galvani, Monica Minarelli, Andrea Rubboli, Davide Bernucci, Stefano Volpato and Gianluca Campo

Subscribe

Subscription
$99.00
Note this is only the net price. Taxes will be calculated during checkout.
  • Immediate online access
  • Full Journal access includes all articles
  • Downloadable in PDF
  • Subscription expires 12/31/2019

Advertisement

About this journal

Electronic ISSN
1573-7241
Print ISSN
0920-3206
Abstracted and indexed in
  1. BIOSIS
  2. Biological Abstracts
  3. CAB Abstracts
  4. Chemical Abstracts Service (CAS)
  5. Current Contents/ Life Sciences
  6. Current Contents/Clinical Medicine
  7. EBSCO Discovery Service
  8. EMBASE
  9. Elsevier Biobase
  10. Gale
  11. Gale Academic OneFile
  12. Google Scholar
  13. Institute of Scientific and Technical Information of China
  14. Japanese Science and Technology Agency (JST)
  15. Journal Citation Reports/Science Edition
  16. Medline
  17. Naver
  18. OCLC WorldCat Discovery Service
  19. Pathway Studio
  20. ProQuest Agricultural & Environmental Science Database
  21. ProQuest Biological Science Database
  22. ProQuest Biotechnology Research Abstracts
  23. ProQuest Central
  24. ProQuest Engineering
  25. ProQuest Environmental Science
  26. ProQuest Health & Medical Collection
  27. ProQuest Health Research Premium Collection
  28. ProQuest Materials Science and Engineering Database
  29. ProQuest Medical Database
  30. ProQuest Natural Science Collection
  31. ProQuest Pharma Collection
  32. ProQuest SciTech Premium Collection
  33. ProQuest Technology Collection
  34. ProQuest-ExLibris Primo
  35. ProQuest-ExLibris Summon
  36. Reaxys
  37. SCImago
  38. SCOPUS
  39. Science Citation Index
  40. Science Citation Index Expanded (SciSearch)
  41. Semantic Scholar
Copyright information

Rights and permissions

Springer Nature policies

© Springer Science+Business Media, LLC, part of Springer Nature